Background
==========

Kleine-Levin syndrome is a rare idiopathic form of episodic hypersomnia that typically occurs during adolescence. The cardinal clinical features are recurrent hypersomnia, accompanied by cognitive disturbances and behavioral abnormalities \[[@B1]\]. The most typical form of classical Kleine-Levin syndrome is associated with hyperphagia \[[@B2],[@B3]\], although hyperphagia is now optional after change of the criteria. Hypersexuality, behavioral disinhibition, delusions, autonomic alteration and hallucinations have also been described, but the patients show normal cognitive function and behavior between attacks. The pathogenesis of Kleine-Levin syndrome is not yet known. Although most cases of recurrent hypersomnia are sporadic, the occurrence of nine familial cases indicate that there may be a genetic predisposition to the syndrome \[[@B4]-[@B8]\] However, no cases of twins affected with Kleine-Levin syndrome have been reported \[[@B9]\]. In this case study we describe monozygotic twins suffering from the syndrome. This is the first case report describing twins affected with Kleine-Levin syndrome thereby supporting the theory that there is an underlying genetic predisposition to the syndrome.

Case presentation
=================

Case 1
------

A 15-year-old boy visited our hospital complaining of recurrent episodes of hypersomnia. His first attack of hypersomnia started at the age of 13, one month after he had been treated with zanamivir for an influenza infection. The episodes of hypersomnia occurred once a month and each lasted for 7 to 10 days. During the symptomatic periods, the patient slept for the entire day except for meals and bathroom visits. He did not exhibit compulsive eating but instead ate less than usual. When questioned, he gave no answer and he later reported that it was difficult to understand what he was told. During the episode, he experienced visual hallucinations such as a fireball. Often, the attacks were immediately preceded by flu-like symptoms. Both of the twins are active baseball players in the middle school team, but both of them did not want to play during and immediately after the episodes. A physical examination of the patient was unremarkable. Between spells, he appeared animated and displayed normal social behavior.

Actimetry recording showed that during attacks, daily activity was lower than that of asymptomatic periods (Figure [1](#F1){ref-type="fig"}). On the other hand, activity during the night was significantly higher than in symptomatic periods. PSG was performed during a symptomatic night and revealed a decrease in sleep efficiency (63.6%, Table [1](#T1){ref-type="table"}). In addition, frequent awakenings were observed during the nocturnal PSG (Figure [2](#F2){ref-type="fig"}A). HLA typing revealed the presence of the DQB1\*0302/0601, DRB1\*0407/1502 allele.

![**Locomotor activity recorded using actimetry.(A)** Actogram records graphed as a double plot showing the locomotor activity of case 1. The actograms show the activity for the period between episodes and that of symptomatic periods. **(B)** Statistical analysis of locomotor activity. Based on bed time of the period between episodes, daily activity (0:00--24:00) was divided into sleep (0:00--7:00) and active (7:00--24:00) times. Data are represented as the mean ± SEM. Asterisks indicate statistically significant differences as determined by a Student's *t*-test (p \< 0.0005).](1471-2377-12-31-1){#F1}

###### 

**Analysis of sleep architecture during symptomatic period (case \#1) and asymptomatic period (case \#2)**

                          **Case \#1**         **Case \#2**
  ------------------- -------------------- ---------------------
   Stage minutes (%)   symptomatic period   asymptomatic period
         Wake              207 (36.4)           13.5 (3.6)
        Stage 1             55 (9.7)              37 (10)
        Stage 2            130 (22.8)           150 (40.5)
        Stage 3             45 (7.9)             21 (5.7)
        Stage 4             39 (6.9)             53 (14.3)
          REM              94 (16.5)             98 (26.4)
     Sleep latency             15                    7
   Sleep efficiency          63.6%                 96.4%
    Total bed time            569                   370

![**Hypnograms of the twin boys.(A)** Hypnograms of case \#1 during symptomatic period. **(B)** Hypnograms of case \#2 during asymptomatic period.](1471-2377-12-31-2){#F2}

Medication using lithium carbonate was initiated and gradually increased to 1000 mg/day with drug monitoring to keep the concentration within therapeutic window (0.8 -- 1.2 mEq/l), and it reduced the frequency of the spells. As of November 2011, he has experienced 23 episodes.

Case 2
------

The monozygotic twin brother of the individual described in case 1 suffered from repeated hypersomnolent spells from the age of 14. The first episode was preceded by an influenza infection that was treated with zanamivir. During episodes, he remained in bed either sleeping or physically inactive. His symptoms lasted for five to seven days, with intervals of three months between spells. He did not exhibit compulsive eating, but he preferred unusually (for him) sour foods. He had difficulty with verbal communication but could write down an answer when questioned. This speech abnormality became less prominent with subsequent spells. Attacks were immediately preceded by a flu-like illness. Between spells, he displayed no psychiatric disorder and maintained normal social and intellectual functions.

Actimetry recording showed that during attacks, activity during the day was lower than that of asymptomatic periods, on the other hand, the activity during night was significantly higher in symptomatic periods. PSG was performed during an asymptomatic night but revealed no significant findings (Table [1](#T1){ref-type="table"}, Figure [2](#F2){ref-type="fig"}B). HLA typing revealed the presence of the DQB1\*0302/0601, DRB1\*0407/1502 allele.

Medication using lithium carbonate was initiated and gradually increased to 600 mg/day with drug monitoring, but it neither prevented nor reduced the duration of the spells. As of November 2011, he has experienced 10 episodes.

Conclusions and discussion
==========================

Sleep disorders involve genetic susceptibility, environmental effects, and interactions between these factors \[[@B10]\]. The heritability of sleep patterns has been reported previously in studies of monozygotic twins, which may assist in the identification of genes involved in sleep disorders \[[@B11]\]. An understanding of sleep regulation at the molecular level is essential in the identification of targets for the treatment of sleep disorders. Although several familial cases of Kleine-Levin syndrome were reported \[[@B4]-[@B8]\], no cases of twins affected with the disease reported \[[@B9]\]. The cases of Kleine-Levin syndrome reported here are exceptional as they occur in monozygotic twins. For both patients the age of onset was similar and the symptoms and clinical course were typical. Actimetry demonstrated increased nocturnal activity and decreased daytime activity during symptomatic periods. PSG revealed low sleep efficiency during attacks, a decreased amount of SWS, sleep onset REM periods and sleep fragmentation. These PSG data are consistent with a previous report \[[@B12]\]. Despite the reduced amplitude in the circadian rhythm of activity, a previous endocrinological study reported no link between an underlying circadian disorder and recurrent hypersomnia \[[@B13]\]. Hypoperfusion \[[@B14]\] or hyperperfusion \[[@B15]\] of thalamus have been reported during the symptomatic period of Kleine-Levin syndrome with Tc-99 m ECD single photon emission tomography (SPECT) which suggest that there is an involvement of this brain tissue in the acute clinical presentation. Based on the generally young age of onset, the recurrence of symptoms and the frequent infectious trigger, an autoimmune etiology for Kleine-Levin syndrome has been suggested. In terms of genetic susceptibility, it has been suggested that the gene polymorphism of HLA-DQB1 is associated with recurrent hypersomnia \[[@B16]\]. However, in a more recent study using a larger independent sample, HLA DR and DQ alleles did not differ between cases and control subjects \[[@B17]\]. Both of the subjects in the case study reported here had been treated for an influenza infection at the onset of the first episode, but we did not identify DQB1\*02. As for narcolepsy, which is a representative primary hypersomnia and has an established linkage with HLA subtype (HLA-DR2, DQB1\*0602), increased onset following 2009 H1N1 winter influenza pandemic were reported recently \[[@B18]\]. Association with HLA is now controversial but the involvement of an autoimmune process remains plausible. Genome-wide mapping studies should be performed using the known familial cases to search for potential linkage. Finally, while this manuscript was under review, another monozygotic twin pair concordant for Kleine-Levin syndrome is reported \[[@B19]\]. Interestingly, they also found DQB1\*0302/\*0601 allele in the twins.
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